hypertension
Gene therapy with human tissue kallikrein reduces hypertension and hyperinsulinemia in fructose-induced hypertensive rats.
Gene therapy with human <span class="gene" id="14568997-0-24-41">tissue kallikrein</span> reduces <span class="disease" id="14568997-0-50-62">hypertension</span> and hyperinsulinemia in fructose-induced hypertensive rats.